FindTrial
Sign In

TO ASSESS THE EFFECTIVENESS OF KETAMINE AS PREMEDICANT FOR PREVENTING FALL IN BLOOD PRESSURE AFTER SPINAL ANAESTHESIA IN PARTURIENTS POSTED FOR ELECTIVE CAESAREAN SECTION- A PROSPECTIVE RANDOMIZED DOUBLE BLIND CONTROLLED STUDY

EFFICACY OF INTRAVENOUS KETAMINE AS PREMEDICANT FOR PREVENTION OF INTRA- OPERATIVE HYPOTENSION AFTER SPINAL ANAESTHESIA IN PARTURIENTS POSTED FOR ELECTIVE CAESAREAN SECTION- A PROSPECTIVE RANDOMIZED DOUBLE BLIND CONTROLLED STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044629
Enrollment
98
Registered
2022-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics Health Condition 2: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: KETAMINE: KETAMINE WILL BE GIVEN TO ONE GROUP AND NORMAL SALINE TO CONTROL GROUP Intervention2: KETAMINE: 15 MG OF KETAMINE BOLUS DOSE WILL BE GIVEN INTRAVENOUSLY TO ONE GROUP JUST BEFO

Sponsors

JSS MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PARTURIENTS OF ASA PHYSICAL CLASS II UNDERGOING ELECTIVE LOWER SEGMENT CAESAREAN SECTION UNDER SPINAL ANAESTHESIA.

Exclusion criteria

Exclusion criteria: 1. CONTRAINDICATIONS TO REGIONAL ANAESTHESIA 2. PARTURIENTS WITH PLACENTA PREVIA, PREECLAMPSIA, CARDIOVASCULAR OR CEREBROVASCULAR DISEASE, GESTATIONAL DIABETES. 3. GESTATIONAL AGE 41 WEEKS. 4. PRE- EXISTING ABNORMAL NEUROLOGICAL OR PSYCHIATRIC DISEASES. 5. HISTORY OF ALLERGY TO KETAMINE. 6. BMI >30 KG/M2. 7. PARTURIENT HEIGHT 170 CM.

Design outcomes

Primary

MeasureTime frame
TO STUDY THE INCIDENCE OF HYPOTENSION AFTER SPINAL ANAESTHESIA IN CAESAREAN SECTION.Timepoint: THE FIRST 60 MINUTES FOLLOWING SPINAL ANAESTHESIA WILL BE CONSIDERED FOR ANAESTHESIA INDUCED HYPOTENSION.—

Secondary

MeasureTime frame
TO STUDY THE POSTOPERATIVE ANALGESIC AND SEDATIVE EFFECT OF KETAMINE, TO STUDY THE FETAL OUTCOME BY ASSESSING THE APGAR SCORETimepoint: 5 MINUTES UPTILL 24 HOURS—

Countries

India

Contacts

Public ContactPROF Dr MANJULA B P

JSS MEDICAL COLLEGE AND HOSPITAL

bpmanjula5@gmail.com9845501226

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026